Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely bisacodyl 5 milligram/1 each gastro-resistant oral tablet (clinical drug) | Is a | Product containing bisacodyl (medicinal product) | false | Inferred relationship | Some | ||
| Product containing precisely bisacodyl 5 milligram/1 each gastro-resistant oral tablet (clinical drug) | Has active ingredient | Bisacodyl (substance) | false | Inferred relationship | Some | ||
| Product containing precisely bisacodyl 5 milligram/1 each gastro-resistant oral tablet (clinical drug) | Has manufactured dose form | Tablet | false | Inferred relationship | Some | ||
| Product containing precisely bisacodyl 5 milligram/1 each gastro-resistant oral tablet (clinical drug) | Has manufactured dose form | Oral tablet | false | Inferred relationship | Some | ||
| Product containing precisely bisacodyl 5 milligram/1 each gastro-resistant oral tablet (clinical drug) | Is a | Product manufactured as oral dose form (product) | false | Inferred relationship | Some | ||
| Product containing precisely bisacodyl 5 milligram/1 each gastro-resistant oral tablet (clinical drug) | Has manufactured dose form | Gastro-resistant oral tablet (dose form) | true | Inferred relationship | Some | ||
| Product containing precisely bisacodyl 5 milligram/1 each gastro-resistant oral tablet (clinical drug) | Is a | Product containing bisacodyl in oral dose form (medicinal product form) | false | Inferred relationship | Some | ||
| Product containing precisely bisacodyl 5 milligram/1 each gastro-resistant oral tablet (clinical drug) | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
| Product containing precisely bisacodyl 5 milligram/1 each gastro-resistant oral tablet (clinical drug) | Has presentation strength denominator value | 1 (qualifier value) | false | Inferred relationship | Some | 1 | |
| Product containing precisely bisacodyl 5 milligram/1 each gastro-resistant oral tablet (clinical drug) | Has precise active ingredient | Bisacodyl (substance) | true | Inferred relationship | Some | 1 | |
| Product containing precisely bisacodyl 5 milligram/1 each gastro-resistant oral tablet (clinical drug) | Has basis of strength substance (attribute) | Bisacodyl (substance) | true | Inferred relationship | Some | 1 | |
| Product containing precisely bisacodyl 5 milligram/1 each gastro-resistant oral tablet (clinical drug) | Has presentation strength denominator unit (attribute) | Tablet (unit of presentation) | true | Inferred relationship | Some | 1 | |
| Product containing precisely bisacodyl 5 milligram/1 each gastro-resistant oral tablet (clinical drug) | Has presentation strength numerator value (attribute) | 5 (qualifier value) | false | Inferred relationship | Some | 1 | |
| Product containing precisely bisacodyl 5 milligram/1 each gastro-resistant oral tablet (clinical drug) | Has unit of presentation | Tablet (unit of presentation) | true | Inferred relationship | Some | ||
| Product containing precisely bisacodyl 5 milligram/1 each gastro-resistant oral tablet (clinical drug) | Count of base of active ingredient | 1 (qualifier value) | false | Inferred relationship | Some | ||
| Product containing precisely bisacodyl 5 milligram/1 each gastro-resistant oral tablet (clinical drug) | Plays role | Laxative therapeutic role | false | Inferred relationship | Some | ||
| Product containing precisely bisacodyl 5 milligram/1 each gastro-resistant oral tablet (clinical drug) | Is a | Bisacodyl only product in oral dose form | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
FHIR